# Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects

> **NCT00996879** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 48 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Midazolam
- **DRUG:** BMS-791325

## Key facts

- **NCT ID:** NCT00996879
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996879, "Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00996879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*